Lennart Hansson

22.8k total citations · 6 hit papers
162 papers, 16.4k citations indexed

About

Lennart Hansson is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Lennart Hansson has authored 162 papers receiving a total of 16.4k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Cardiology and Cardiovascular Medicine, 34 papers in Endocrinology, Diabetes and Metabolism and 18 papers in Surgery. Recurrent topics in Lennart Hansson's work include Blood Pressure and Hypertension Studies (93 papers), Hormonal Regulation and Hypertension (31 papers) and Sodium Intake and Health (14 papers). Lennart Hansson is often cited by papers focused on Blood Pressure and Hypertension Studies (93 papers), Hormonal Regulation and Hypertension (31 papers) and Sodium Intake and Health (14 papers). Lennart Hansson collaborates with scholars based in Sweden, United States and Italy. Lennart Hansson's co-authors include Alberto Zanchetti, Björn Dahlöf, Stevo Julius, Dag Elmfeldt, Hans Wedel, Thomas Hedner, Joël Ménard, S. George Carruthers, K. H. Rahn and S. Westerling and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Circulation.

In The Last Decade

Lennart Hansson

158 papers receiving 15.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial

1998 4.0k citations Lennart Hansson, Alberto Zanchetti et al. The Lancet profile →
Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR

2003 2.3k citations Lennart Hansson et al. profile →
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

2004 1.8k citations Stevo Julius, Sverre E. Kjeldsen et al. The Lancet profile →
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1999 1.5k citations Lennart Hansson, Lars Lindholm et al. The Lancet profile →
The Study on Cognition and Prognosis in the Elderly (SCOPE)

2003 1.0k citations Lennart Hansson, Alberto Zanchetti et al. Journal of Hypertension profile →
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1999 1.0k citations Lennart Hansson, Lars Lindholm et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lennart Hansson Sweden	39	11.0k	5.3k	2.2k	2.1k	1.7k	162	16.4k
Dick de Zeeuw Netherlands	95	19.0k 1.7×	19.5k 3.7×	7.7k 3.6×	1.8k 0.9×	3.5k 2.1×	825	53.1k
Anna F. Dominiczak United Kingdom	66	9.8k 0.9×	3.9k 0.8×	2.9k 1.3×	510 0.2×	833 0.5×	358	22.1k
Roland E. Schmieder Germany	74	20.0k 1.8×	7.8k 1.5×	4.0k 1.8×	296 0.1×	1.3k 0.8×	623	29.3k
C. T. Dollery United Kingdom	62	4.2k 0.4×	1.8k 0.3×	1.7k 0.8×	605 0.3×	1.5k 0.9×	310	15.2k
G. Wilkinson United States	93	1.4k 0.1×	1.2k 0.2×	1.6k 0.7×	1.3k 0.6×	2.5k 1.5×	403	35.3k
James D. Otvos United States	66	3.4k 0.3×	7.8k 1.5×	6.1k 2.8×	247 0.1×	385 0.2×	255	17.2k
Hans‐Henrik Parving Denmark	71	8.4k 0.8×	8.9k 1.7×	2.2k 1.0×	229 0.1×	1.4k 0.8×	232	20.8k
William B. White United States	63	11.3k 1.0×	7.7k 1.5×	4.5k 2.1×	86 0.0×	2.3k 1.4×	440	21.7k
H Bryan Brewer United States	58	4.6k 0.4×	8.3k 1.6×	9.8k 4.5×	228 0.1×	774 0.5×	152	21.8k
Gary F. Mitchell United States	76	18.5k 1.7×	1.6k 0.3×	3.0k 1.4×	209 0.1×	318 0.2×	266	24.4k

Countries citing papers authored by Lennart Hansson

Since Specialization

Citations

This map shows the geographic impact of Lennart Hansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lennart Hansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lennart Hansson more than expected).

Fields of papers citing papers by Lennart Hansson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lennart Hansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lennart Hansson. The network helps show where Lennart Hansson may publish in the future.

Co-authorship network of co-authors of Lennart Hansson

This figure shows the co-authorship network connecting the top 25 collaborators of Lennart Hansson. A scholar is included among the top collaborators of Lennart Hansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lennart Hansson. Lennart Hansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kjeldsen, Sverre E., Thomas Hedner, Jan Otto Syvertsen, et al.. (2002). Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study. Journal of Hypertension. 20(6). 1231–1237. 24 indexed citations

Hansson, Lennart, Adam Lloyd, Pippa Anderson, & Zoë Kopp. (2002). Excess Morbidity and Cost of Failure to Achieve Targets for Blood Pressure Control in Europe. Blood Pressure. 11(1). 35–45. 47 indexed citations

Kjeldsen, Sverre E., Ingrid Os, Csaba Farsang, et al.. (2000). European Society of Hypertension Scientific Newsletter, Update on Hypertension Management. Journal of Hypertension. 18(9). 1345–1346. 10 indexed citations

Hansson, Lennart. (2000). Results of the STOP-Hypertension-2 Trial. Blood Pressure. 9(sup2). 17–20. 17 indexed citations

Hansson, Lennart. (1999). Treatment of Hypertension and the J Curve.. PubMed. 1(2). 136–140. 6 indexed citations

Hansson, Lennart. (1999). Concluding Remarks. Clinical Pharmacokinetics. 37(Supplement 1). 33–38. 2 indexed citations

Messerli, Franz H., et al.. (1998). Panel Discussion: Morbidity and Mortality with Dihydropyridines - the True Benefits Emerge. Blood Pressure. 7(sup1). 33–34.

Sonesson, Clas, et al.. (1997). OSU6182 a representative from a unique class of functional modulators of dopaminergic systems. The Society for Neuroscience Abstracts. 23. 531. 3 indexed citations

Himmelmänn, Anders, et al.. (1994). Predictors of Blood Pressure and Left Ventricular Mass in the Young: The Hypertension in Pregnancy Offspring Study. American Journal of Hypertension. 7(5). 381–389. 9 indexed citations

10.

Zanchetti, Alberto, John Chalmers, Kikuo Arakawa, et al.. (1993). 1993 Guidelines for the management of mild hypertension: MEMORANDUM from a World Health Organization/International Society of Hypertension meeting. Journal of Hypertension. 11(9). 905–918. 203 indexed citations

11.

Hansson, Lennart. (1991). Review of state-of-the-art beta-blocker therapy. The American Journal of Cardiology. 67(10). B43–B46. 3 indexed citations

12.

Hansson, Lennart. (1990). Isradipine in Hypertension. Drugs. 40(Supplement 2). 10–14. 6 indexed citations

13.

Hansson, Lennart, et al.. (1989). Mechanisms in hypertension : new aspects in hemodynamics. Raven Press eBooks. 6 indexed citations

14.

Hansson, Lennart. (1989). Antipathological Potential of β-Blockers. Journal of Cardiovascular Pharmacology. 14. S1–3. 1 indexed citations

15.

Hedner, Thomas & Lennart Hansson. (1988). A Utilitarian or Deontological Approach Toward Primary Prevention of Cardiovascular Disease?. Acta Medica Scandinavica. 224(4). 293–302. 4 indexed citations

16.

Hansson, Lennart. (1987). What Have We Achieved?. Journal of Cardiovascular Pharmacology. 10. S151–S151. 1 indexed citations

17.

Dahlöf, Björn, Lennart Andrén, Robert Eggertsen, et al.. (1987). Addition of the Calcium Antagonist PN 200–110 to Pindolol Markedly Augments the Antihypertensive Effect in Essential Hypertension. Journal of Cardiovascular Pharmacology. 10. S102–104. 4 indexed citations

18.

Hansson, Lennart, et al.. (1986). Pan-European business services by satellite: A study of the potential future demand. NASA STI/Recon Technical Report N. 87. 28810.

19.

Gudbrandsson, Thorkell, Hans Herlitz, Lennart Hansson, Leif Lindholm, & Lars Nilsson. (1981). IMMUNOLOGICAL CHANGES IN PATIENTS WITH PREVIOUS MALIGNANT ESSENTIAL HYPERTENSION. The Lancet. 317(8217). 406–408. 59 indexed citations

20.

Hansson, Lennart. (1977). Effects of Beta‐Adrenoceptor Blocking Agents on Haemodynamic Parameters. Acta Medica Scandinavica. 202(S606). 49–54. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact